Vivorte's Series A - II Round

Vivorte raised a round of funding on August 01, 2012. Investors include Yearling Fund.

Vivorte is commercializing two orthopedic devices that established companies have confirmed they need in their pipelines: a minimally invasive implantable device designed to reduce hip fractures and s…

Articles about Vivorte's Series A - II Round: